| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01713979 |
| P698 | PubMed publication ID | 7699153 |
| P2093 | author name string | Chow AW | |
| Azar RM | |||
| P2860 | cites work | Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 | Q24671879 |
| Nephrotoxicity of vancomycin, alone and with an aminoglycoside | Q28335291 | ||
| Vancomycin enhancement of experimental tobramycin nephrotoxicity | Q28362084 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis | Q35251599 | ||
| Vancomycin pharmacokinetics in burn patients and intravenous drug abusers | Q35253581 | ||
| Application of a Bayesian method to monitor and adjust vancomycin dosage regimens | Q35261758 | ||
| Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters | Q35341106 | ||
| Pharmacokinetics of teicoplanin in renal failure | Q35541154 | ||
| Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment | Q35542699 | ||
| Pharmacokinetics of vancomycin in patients with various degrees of renal function | Q35758814 | ||
| A review of the safety profile of teicoplanin | Q37091081 | ||
| An updated comparison of drug dosing methods. Part IV: Vancomycin | Q37742573 | ||
| Vancomycin therapeutic drug monitoring: is it necessary? | Q38566835 | ||
| Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children. | Q38635660 | ||
| Vancomycin: an update | Q39746652 | ||
| Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients | Q40723910 | ||
| Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis | Q40731129 | ||
| Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin | Q41894860 | ||
| A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria | Q42067909 | ||
| Tubulointerstitial nephritis due to vancomycin | Q42192368 | ||
| Mild nephrotoxicity associated with vancomycin use. | Q42198840 | ||
| A prospective study of adverse reactions associated with vancomycin therapy | Q42226234 | ||
| Vancomycin toxicity: a prospective study | Q42228839 | ||
| Toxicology of vancomycin in laboratory animals | Q42271152 | ||
| Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients | Q42651257 | ||
| Vancomycin and nephrotoxicity | Q42702730 | ||
| Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration | Q44019964 | ||
| Methicillin-resistant Staphylococcus aureus osteomyelitis | Q49298863 | ||
| Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy. | Q51742469 | ||
| Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms. | Q52650203 | ||
| A simplified dosing method for initiating vancomycin therapy. | Q53810372 | ||
| Teicoplanin nephrotoxicity: first case report. | Q54279275 | ||
| Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. | Q54395876 | ||
| Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1 | Q67571950 | ||
| Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance | Q67781827 | ||
| Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans | Q67904144 | ||
| Necessity of a loading dose when using vancomycin in critically ill patients | Q68159011 | ||
| Clinical pharmacokinetics of teicoplanin | Q68414624 | ||
| Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin | Q68499819 | ||
| Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy | Q69125970 | ||
| Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients | Q69387065 | ||
| Effect of intravenous vancomycin on renal function | Q69748690 | ||
| Vancomycin therapy for methicillin-resistant Staphylococcus aureus | Q70444786 | ||
| Renal tolerance and pharmacokinetics of vancomycin in rats | Q70648314 | ||
| Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for Dosage | Q72417776 | ||
| Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage | Q93571562 | ||
| P304 | page(s) | S23-9 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Glycopeptides and nephrotoxicity | |
| P478 | volume | 20 Suppl 4 |
| Q30245199 | Adverse safety events in patients with Chronic Kidney Disease (CKD). |
| Q33604536 | Antibacterial-induced nephrotoxicity in the newborn |
| Q44262559 | Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants |
| Q46100350 | Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats |
| Q40902529 | Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity |
| Q34731462 | Drug-induced impairment of renal function |
| Q36322918 | Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children |
| Q42385439 | Evaluation of the Safety of a Vancomycin Nomogram Used to Achieve Target Trough Concentrations |
| Q52081441 | High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures. |
| Q34472677 | Renal transport of antibiotics and nephrotoxicity: a review |
| Q43453462 | Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. |
| Q87560192 | Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis |
| Q35826283 | Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration |
| Q37992997 | Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review |
Search more.